OUR TEAM
Office Team
RAFFAELA DIETRICH, MA. RER. NAT.
Projectmanager
- Place of Home: Saalfelden
- I’m working for CRS since: October 2016
- Working experience in clinical research: October 2016
- Indication field and Patient numbers:
- Allergy
- Oncology
- Gynaecology
- Intensive Care
- Paediatrics
- Covid-19
BARBARA RIEDLSPERGER, MAG.JUR.
Projectmanager, EC submissions, authority submissions, Contract Management
- Place of Home: Maria Alm
- I’m working for CRS since: 2004
- Working experience in clinical research: 12 years
- Indication field and Patient numbers:
- Oncology
- Cardiovascular diseases
- Metabolic diseases
- Neurology
- Infective diseases
- Immunology
- Gynaecology Postmenopause
REINHARD RIEDLSPERGER, MAG
Managing Director
- Place of Home: Maria Alm
- I’m working for CRS since: the company exists (2004)
- Working experience in clinical research: 20 years
- Indication field and Patient numbers:
- Oncology –> 500 patients
- Transplantation – 20 patients
- Infectious diseases – 100 patients
- Rheumatic diseases – 250 patients
- Metabolic diseases – 50 patients
- Neurology – 250 patients
- Gynaecology – 80 patients
CRA Team
MAG. HONORATA DONNERMAIR
Clinical Research Associate
- Place of Home: Ried in Innkreis
- I’m working for CRS since: 2017
- Working experience in clinical research: 8 Years
- Indication field and patient numbers:
- Traumatic brain injury (MPG) – 68 patients
- Traumatic brain injury (AMG) – 7 patients
- SAH (subarachnoid hemorrhage ) – 8 patients
- SAH (subarachnoid haemorrhage enteral nutritional product) – 13 patients
- SRSE ( Super-refractory status epilepticus) – 1 patient
- Lung Fibrosis phase III – 150 patients
- Oncolytic virus Phase I study, dose escalation – 117 patients
- Crohn’s Disease phase IIa – 100 patients
- Clinically significant portal hypertension (CSPH) Phase II – 230 patients
- SVT Supraventricular Tachycardia in Pediatric Patients
- COVID-19 phase II/III
- CTBI – international register study – 120 patients
- ICH – national register study – 270 patients
- Acute (meningo)-encephalitis (AE) register- 20 patients
- Inflammatory Bowel Disease (IBD) national register – 200 patients
- Alpha-1- Antitripsnmangel register
DR. TATJANA MORY-PÖNISCH
Clinical Research Associate
- Place of Home: Mondsee
- I’m working for CRS since: 2012
- Working experience in clinical research: 23 Years
- Indication field and patient numbers:
- Oncology – 1000 patients
- Transplantation – 500 patients
- Infectious diseases – 10 patients
- Respiratory – 50 patients
- Gastroenterology – 20 patients
- Radiology – 40 patients
- Medical device studies – 100 patients
MAG. RER. NAT. NICOLE ODER, MAS
Clinical Research Associate
- Place of Home: Guntramsdorf
- I’m working for CRS since: 2010
- Working experience in clinical research: 20 Years
- Indication field and patient numbers:
- Pulmonary arterial hypertension – 7 patients
- Colon cancer – 32 patients
- Pancreatic ductal adenocarcinoma – 14 patients
- Metastatic colorectal, gastroesophageal and renal cell carcinoma – 5 patients
- Acute myeloid leucaemia – 12 patients
- Diffuse large B-Cell lymphoma – 16 patients
- Chronic myelogenous leucaemia – 16 patients
- Myelofibrosis – 9 patients
- Gastrointestinal stromal tumor – 18 patients
- Hepatocellular carcinoma – 18 patients
- Multiple myeloma – 18 patients
- Knee and hip osteoarthritis with chronic pain – 45 patients
- Chronic malignant tumor-related pain – 10 patients
- Enteral nutrition in gastrointestinal tumor patients – 205 patients
- Malnutrient surgical patients – 60 patients
- Breast cancer – 47 patients
- Advanced breast cancer – 249 patients
- Allergic rhinitis – 72 patients
- Atrial fibrillation/atrial flutter – 20 patients
- Heart failure – 81 patients
- Hypercholesterolemia – 47 patients
- Graft versus host disease – 22 patients
- Epileptic seizure – 6 patients
- Diabetic macular edema – 25 patients
- COVID-19 – 209 patients
- Essential thrombocytopenia – 10 patients
MAG. MARTINA GÖRNER
Clinical Research Associate, Project Manager
- Place of Home: Vienna
- I’m working for CRS since: 2004
- Working experience in clinical research: 27 Years
- Indication field and patient numbers:
- Oncology – 220 patients
- Rheumatology – 10 patients
- Diabetes – 30 patients
- Dermatology – 50 patients
- Allergology – 250 patients
- Infectious diseases – 50 patients
- Respiratory – 100 patients
- Gastroenterology – 70 patients
- Urology – 50 patients
- Clinical Pharmacology/Early Clinical Development – 30 patients
